Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q

Human Pathology

Volumn 39, Issue 11, 2008, Pages 1621-1629

  Riener, Marc Oliver ^a,b   Nikolopoulos, Elisabeth ^a   Herr, Alexander ^c   Wild, Peter Johannes ^b   Hausmann, Michael ^a,d   Wiech, Thorsten ^a   Orlowska Volk, Marzenna ^a   Lassmann, Silke ^a   Walch, Axel ^e   Werner, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Biotype AG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cadherin 13; Microarray based CGH; Tubular breast carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER GROWTH; CARCINOMA IN SITU; CHROMOSOME 16Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE LOSS; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; ONCOGENE; PRINCIPAL COMPONENT ANALYSIS; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHROMOSOMES, HUMAN, PAIR 16; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROARRAY ANALYSIS; MICROSCOPY, FLUORESCENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 54049091898     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.02.021     Document Type: Article

References (35)

1. Carstens P.H., Greenberg R.A., Francis D., and Lyon H. Tubular carcinoma of the breast. A long term follow-up. Histopathology 9 (1985) 271-280
2. McBoyle M.F., Razek H.A., Carter J.L., and Helmer S.D. Tubular carcinoma of the breast: an institutional review. Am Surg 63 (1997) 639-644 [discussion 644-5]
3. Livi L., Paiar F., Meldolesi E., et al. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. Eur J Surg Oncol 31 (2005) 9-12
4. Leonard C.E., Howell K., Shapiro H., Ponce J., and Kercher J. Excision only for tubular carcinoma of the breast. Breast J 11 (2005) 129-133
5. Tavassoli F.A. DPE. World Health Organization classification of tumours. Pathology and genetics of the breast and female genital organs (2003), IARC Press, Lyon
6. Vo T., Xing Y., Meric-Bernstam F., et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194 (2007) 527-531
7. Goldstein N.S., Kestin L.L., and Vicini F.A. Refined morphologic criteria for tubular carcinoma to retain its favorable outcome status in contemporary breast carcinoma patients. Am J Clin Pathol 122 (2004) 728-739
8. Fasano M., Vamvakas E., Delgado Y., et al. Tubular carcinoma of the breast: immunohistochemical and DNA flow cytometric profile. Breast J 5 (1999) 252-255
9. Diab S.G., Clark G.M., Osborne C.K., Libby A., Allred D.C., and Elledge R.M. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 17 (1999) 1442-1448
10. Buerger H., Otterbach F., Simon R., et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189 (1999) 521-526
11. Waldman F.M., Hwang E.S., Etzell J., et al. Genomic alterations in tubular breast carcinomas. Hum Pathol 32 (2001) 222-226
12. Schraml P., Schwerdtfeger G., Burkhalter F., et al. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163 (2003) 985-992
13. Hui A.B., Lo K.W., Yin X.L., Poon W.S., and Ng H.K. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 81 (2001) 717-723
14. Wiech T., Timme S., Riede F., et al. Human archival tissues provide a valuable source for the analysis of spatial genome organization. Histochem Cell Biol 123 (2005) 229-238
15. Sturn A., Quackenbush J., and Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 18 (2002) 207-208
16. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
17. Albrecht B., Hausmann M., Zitzelsberger H., et al. Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. J Pathol 203 (2004) 780-788
18. Haber M., Smith J., Bordow S.B., et al. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. J Clin Oncol 24 (2006) 1546-1553
19. Wadehra M., Natarajan S., Seligson D.B., et al. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer 107 (2006) 90-98
20. Gallucci M., Guadagni F., Marzano R., et al. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters. J Clin Pathol 58 (2005) 367-371
21. Bieche I., and Lidereau R. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Mol Carcinog 29 (2000) 151-158
22. Hellerbrand C., Bumes E., Bataille F., Dietmaier W., Massoumi R., and Bosserhoff A.K. Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis (2006)
23. Pluciennik E., Kusinska R., Potemski P., Kubiak R., Kordek R., and Bednarek A.K. WWOX-the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol 32 (2006) 153-157
24. Tischkowitz M.D., Morgan N.V., Grimwade D., et al. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 18 (2004) 420-425
25. Gamallo C., Palacios J., Suarez A., et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142 (1993) 987-993
26. Moll R., Mitze M., Frixen U.H., and Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143 (1993) 1731-1742
27. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451-1455
28. Toyooka K.O., Toyooka S., Virmani A.K., et al. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61 (2001) 4556-4560
29. Takeuchi T., Misaki A., Chen B.K., and Ohtsuki Y. H-cadherin expression in breast cancer. Histopathology 35 (1999) 87-88
30. Lee S.W. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 2 (1996) 776-782
31. Shelley Hwang E., Nyante S.J., Yi Chen Y., et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100 (2004) 2562-2572
32. Hwang E.S., DeVries S., Chew K.L., et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 10 (2004) 5160-5167
33. Acs G., Lawton T.J., Rebbeck T.R., LiVolsi V.A., and Zhang P.J. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115 (2001) 85-98
34. Rakha E.A., Armour J.A., Pinder S.E., Paish C.E., and Ellis I.O. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. Int J Cancer 114 (2005) 720-729
35. van Wezel T., Lombaerts M., van Roon E.H., et al. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Breast Cancer Res 7 (2005) R998-R1004